Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition

NCT01445067 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: BMS-927711 (CGRP Antagonist)
DRUG: BMS-927711 (CGRP Antagonist)

Sponsor

Pfizer